Epigenome Research Center, China Medical University Hospital, Taichung, Taiwan; Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan.
Epigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Environ Toxicol Pharmacol. 2014 Nov;38(3):821-8. doi: 10.1016/j.etap.2014.09.010. Epub 2014 Sep 28.
We developed a CYP2D6 genotyping method that required only one polymerase chain reaction (PCR) followed by a high-resolution melting curve analysis (HRM) and DNA sequencing. DNA was extracted from peripheral blood samples obtained from 100 normal individuals. From the HRM analysis using three fragments of amplicons (exons 1, 6, and 9), we successfully identified four common CYP2D6 gene polymorphisms (100C>T, 2850C>T, 2988G>A, and 4180G>C). Exons 3 and 7 were also screened by HRM analysis. The heteroduplexes, wild-type homoduplexes, and homoduplexes of compound mutations showed distinct melting plots. The other four exons (exons 2, 4, 5, and 8) were directly analyzed by DNA sequencing. In conclusion, we developed an HRM and DNA sequencing based method to assess the CYP2D6 gene directly without the need for nested PCR. This method is quick and cost-effective; it reduces the chance of PCR contamination and is suitable for clinical application.
我们开发了一种 CYP2D6 基因分型方法,仅需一次聚合酶链反应(PCR),随后进行高分辨率熔解曲线分析(HRM)和 DNA 测序。从 100 名正常个体的外周血样本中提取 DNA。通过对三个扩增片段(外显子 1、6 和 9)进行 HRM 分析,我们成功鉴定了四种常见的 CYP2D6 基因突变(100C>T、2850C>T、2988G>A 和 4180G>C)。外显子 3 和 7 也通过 HRM 分析进行了筛选。杂合双链体、野生型同源双链体和复合突变的同源双链体显示出不同的熔解图谱。其他四个外显子(外显子 2、4、5 和 8)则直接通过 DNA 测序进行分析。总之,我们开发了一种基于 HRM 和 DNA 测序的方法,无需巢式 PCR 即可直接评估 CYP2D6 基因。该方法快速且具有成本效益,降低了 PCR 污染的可能性,适用于临床应用。